Tag: Humacyte

access graft technologies

Bright future for access grafts highlighted at VASBI 2021 with multiple...

New technologies intended to improve the often-mixed outcomes associated with arteriovenous grafts (AVGs) for haemodialysis access were on display at this year’s Vascular Access...

Humacyte to present long-term follow-up data from Phase 2 vascular access...

Humacyte has announced that the clinical results of five-year outcomes in patients receiving the human acellular vessels (HAV) for arteriovenous (AV) access in haemodialysis...